About
Advancing the Science of Primatology Through Open Access Publishing
At IgMin Research, we are dedicated to promoting scholarly excellence in primatology, the scientific study of primates including their behavior, genetics, ecology, and evolution. We invite researchers and academicians to contribute original studies, reviews, and insights through our streamlined primatology journal submission system.
Our platform ensures fast, fair peer review and high visibility for your work, enhancing global reach and academic impact.
Key Highlights:
Quick Submission: Submit your research effortlessly using our user-friendly online form.
Manuscript Guidelines: Prepare your manuscript to meet the standards of leading primatology open-access journals.
Submit Primatology Research: Share groundbreaking findings on primate biology, conservation, and behavior.
As an open-access journal, we ensure that your primatology research reaches scientists, conservationists, and institutions worldwide—without barriers
Why publish with us?
Global Visibility – Indexed in major databases
Fast Peer Review – Decision within 14–21 days
Open Access – Maximize readership and citation
Multidisciplinary Scope – Biology, Medicine and Engineering
Editorial Board Excellence – Global experts involved
University Library Indexing – Via OCLC
Permanent Archiving – CrossRef DOI
APC – Affordable APCs with discounts
Citation – High Citation Potential
Which articles are now trending?
Research Articles
- Analytical Expressions of the Markov Chain of K-Ras4B Protein within the Catalytic Environment and a New Markov-State Model
- The Cancer Stem Cell Concept as Applied to Prostate Cancer
- Adaptation of the Physical Literacy Scale for Adults into Turkish and Examination of its Psychometric Properties
- The Examination of Game Skills of Children Aged 5-6 Years Participating in Movement Education
- On how Doping with Atoms of Gadolinium and Scandium affects the Surface Structure of Silicon
- Examining the Causal Connection between Lipid-lowering Medications and Malignant Meningiomas through Drug-target Mendelian Randomization Analysis
Advertisement


